$49.28 25.8%
HIMS Stock Price vs. AI Score
Data gathered: February 22

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - hims (HIMS)

Analysis generated February 21, 2025. Powered by Chat GPT.

Hims, Inc. is a telehealth company primarily focused on providing healthcare services and products directly to consumers. The company offers treatments for conditions such as hair loss, erectile dysfunction, and mental health concerns. Hims operates a direct-to-consumer business model, leveraging an online platform to facilitate doctor consultations and medication delivery. This approach aims to provide convenience and privacy to its customers, appealing to a broad demographic looking for accessible healthcare solutions.

Read full AI stock Analysis

Stock Alerts - hims (HIMS)

company logo hims | February 21
Price is down by -19.3% in the last 24h.
company logo hims | February 21
Insider Alert: Chi Michael is continuing selling shares
company logo hims | February 21
Business Outlook among employees is up by 5.3% over the last month.
company logo hims | February 20
News Alert: Hims & Hers acquires at-home-testing company

About hims

Hims & Hers Health, Inc. is a telemedicine company that operates Hims and Hers, which sell men's and women's personal care products. Hims, Inc. was founded in 2017 with the launch of Hims, and Hers was launched in 2018. In January 2019, Hims became the second-fastest startup to become a so-called 'unicorn' after Bird.


hims
Price $49.28
Target Price Sign up
Volume 88,610,000
Market Cap $14.5B
Year Range $13.65 - $68.74
Dividend Yield 0%
PE Ratio 150.93
Analyst Rating 43% buy
Earnings Date February 24 '25
Industry Retail

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24402M84M318M76M23M0.320
Q2 '24316M59M257M13M12M0.060
Q1 '24278M49M229M11M11M0.050
Q4 '23247M43M204M1.2M300,0000.010
Q3 '23227M39M187M-7.6M-7.8M-0.040

Insider Transactions View All

Chi Michael filed to sell 193,601 shares at $59.3.
February 20 '25
Dudum Andrew filed to sell 97,687 shares at $59.7.
February 20 '25
Boughton Soleil filed to sell 157,345 shares at $60.7.
February 20 '25
Dudum Andrew filed to sell 427,796 shares at $59.5.
February 20 '25
Dudum Andrew filed to sell 98,487 shares at $58.3.
February 20 '25

What is the Market Cap of hims?

The Market Cap of hims is $14.5B.

What is hims' PE Ratio?

As of today, hims' PE (Price to Earnings) ratio is 150.93.

When does hims report earnings?

hims will report its next earnings on February 24 '25.

What is the current stock price of hims?

Currently, the price of one share of hims stock is $49.28.

How can I analyze the HIMS stock price chart for investment decisions?

The HIMS stock price chart above provides a comprehensive visual representation of hims' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling hims shares. Our platform offers an up-to-date HIMS stock price chart, along with technical data analysis and alternative data insights.

Does HIMS offer dividends to its shareholders?

As of our latest update, hims (HIMS) does not offer dividends to its shareholders. Investors interested in hims should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of hims?

Some of the similar stocks of hims are Costco, Dollar Tree, Target, Macy's, and Best Buy.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.